January 3, 2011

This past year saw a lower-than-usual number of new drugs approved by the Food and Drug Administration, due in part to delays at the agency, according to published reports.

December 21, 2010

A biopharmaceutical company exclusively will develop and commercialize oral formulations of a drug maker's insulins.

December 20, 2010

Drug maker Amylin Pharmaceuticals has submitted the first of a series of sections of a regulatory approval application for a biotech drug to treat patients with a rare lipid disorder.

December 9, 2010

Combining a diabetes drug marketed by Eli Lilly and Amylin Pharmaceuticals controls blood sugar and promotes weight loss more than insulin alone, according to a new study.

December 7, 2010

Supplier News — Fera Pharmaceuticals has recently launched two new topical ointments. The New York-based company has developed Ilotycin (erythromycin) and Garamycin (gentamicin) ophthalmic ointments, both for the treatment of bacterial infections of the eye. “Our goal is simple: to keep more quality healthcare choices alive for the people who need them,” company co-founder Frank DellaFera said.


December 2, 2010

A growing drug-treated population will cause the Type 2 diabetes drug market in China to increase to $2.5 billion by 2014 ...

December 2, 2010

Merck announced on Thursday it has inked a deal to acquire an insulin maker.

November 17, 2010

A Type 2 diabetes drug marketed by Eli Lilly and Amylin Pharmaceuticals may lower the...

November 15, 2010

A leading charitable funder of and advocate for Type 1 diabetes research and a drug...

November 7, 2010

The Food and Drug Administration approved the first and only once-a-day metformin extended-release plus dipeptidyl...

November 7, 2010

A new study conducted by University of Toronto researchers found that GLP-1 analogues not only...

November 2, 2010

The Food and Drug Administration has turned down an application for an insulin product made...

November 2, 2010

The CEO of drug maker Eli Lilly has called for a “wave of invention” to...

October 31, 2010

Supermarket chain Stater Bros. will mark National Diabetes Awareness Month by offering free diabetes drugs...

October 27, 2010

An insurance company and a patient assistance program have joined forces to improve medication adherence...

October 27, 2010

Many Type 2 diabetes patients who use the drug Onglyza (saxagliptin) switched to that drug...

October 24, 2010

Speculation has emerged that Eli Lilly may seek to acquire several other companies in light...

October 19, 2010

The Food and Drug Administration declined to approve a long-anticipated diabetes drug made by Eli...

October 17, 2010

Pfizer has entered the world of biosimilars through a deal with India-based Biocon to distribute...

September 30, 2010

UltiMed, a company that makes insulin-delivery devices, has named a new executive....

September 23, 2010

An investigational diabetes drug works as well as a generic already on the market, according...

September 22, 2010

The Food and Drug Administration has moved to significantly restrict access to a controversial diabetes...

September 19, 2010

An injected insulin made by French drug maker Sanofi-Aventis provided further reduction of blood sugar...

September 19, 2010

An investigational treatment made by French drug maker Sanofi-Aventis showed “significant” improvement in blood-glucose control...